Pablo Íñigo

835 total citations
22 papers, 583 citations indexed

About

Pablo Íñigo is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Pablo Íñigo has authored 22 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Transplantation. Recurrent topics in Pablo Íñigo's work include Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (3 papers) and Dialysis and Renal Disease Management (3 papers). Pablo Íñigo is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Renal Diseases and Glomerulopathies (3 papers) and Dialysis and Renal Disease Management (3 papers). Pablo Íñigo collaborates with scholars based in Spain, France and United States. Pablo Íñigo's co-authors include Josep M. Campistol, Sergio Lario, Federico Oppenheimer, Francisca Rivera, Wladimiro Jiménez, M Bescós, Joaquim Mullol, Ferrán Morell, Juan Ruiz-Manzano and Antoni Xaubet and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Kidney International and Clinical Chemistry.

In The Last Decade

Pablo Íñigo

21 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Íñigo Spain 11 202 156 152 129 92 22 583
B Fellström Sweden 14 94 0.5× 76 0.5× 194 1.3× 223 1.7× 102 1.1× 38 557
Margrét B. Andrésdóttir Iceland 15 179 0.9× 129 0.8× 135 0.9× 61 0.5× 447 4.9× 20 747
S O Bohman Sweden 12 129 0.6× 79 0.5× 247 1.6× 182 1.4× 215 2.3× 18 676
Ivo Lukitsch United States 7 67 0.3× 93 0.6× 102 0.7× 194 1.5× 164 1.8× 12 644
Maria Van Dyck Belgium 18 112 0.6× 116 0.7× 33 0.2× 100 0.8× 240 2.6× 37 870
Blaise Robin France 13 70 0.3× 123 0.8× 95 0.6× 87 0.7× 64 0.7× 25 571
G Rifle France 16 165 0.8× 87 0.6× 67 0.4× 107 0.8× 131 1.4× 70 580
T Haba Japan 17 150 0.7× 160 1.0× 200 1.3× 330 2.6× 734 8.0× 53 1.1k
Julie Riopel Canada 13 145 0.7× 107 0.7× 287 1.9× 180 1.4× 175 1.9× 28 656
Mazen Arar United States 14 124 0.6× 388 2.5× 48 0.3× 133 1.0× 313 3.4× 25 923

Countries citing papers authored by Pablo Íñigo

Since Specialization
Citations

This map shows the geographic impact of Pablo Íñigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Íñigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Íñigo more than expected).

Fields of papers citing papers by Pablo Íñigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Íñigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Íñigo. The network helps show where Pablo Íñigo may publish in the future.

Co-authorship network of co-authors of Pablo Íñigo

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Íñigo. A scholar is included among the top collaborators of Pablo Íñigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Íñigo. Pablo Íñigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Pérez, Antonio, Samuel J. Martínez‐Domínguez, Ángel Lanas, Pablo Íñigo, & Luis A. Garcı́a Rodrı́guez. (2024). Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing Users. Journal of General Internal Medicine. 40(4). 818–827.
2.
Rubio‐Gracia, Jorge, Marta Sánchez‐Marteles, Vanesa Garcés‐Horna, et al.. (2022). Elevated urinary Kidney Injury Molecule 1 (KIM-1) at discharge strongly predicts early mortality following an episode of acute decompensated heart failure. Polskie Archiwum Medycyny Wewnętrznej. 132(9). 3 indexed citations
3.
Íñigo, Pablo, et al.. (2014). Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats. Diabetology & Metabolic Syndrome. 6(1). 10–10. 6 indexed citations
4.
Martínez‐Beamonte, Roberto, María Á. Navarro, Mark Strunk, et al.. (2011). Selection of reference genes for gene expression studies in rats. Journal of Biotechnology. 151(4). 325–334. 44 indexed citations
5.
Íñigo, Pablo, et al.. (2010). Adolescente con insuficiencia renal aguda y pérdida de agudeza visual. 3(1). 51–54. 1 indexed citations
6.
Coll, Elisabeth, Bru Cormand, Begoña Campos, et al.. (2005). Association of TGF-beta1 polymorphisms with chronic renal disease.. PubMed. 17(6). 794–9. 17 indexed citations
7.
Gregorio, M.A. De, et al.. (2004). Retrievability of Uncoated Versus Paclitaxel-coated Günther-Tulip IVC Filters in an Animal Model. Journal of Vascular and Interventional Radiology. 15(7). 719–726. 17 indexed citations
8.
Xaubet, Antoni, Sergio Lario, Julio Ancochea, et al.. (2003). Transforming Growth Factor-β1 Gene Polymorphisms Are Associated with Disease Progression in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 168(4). 431–435. 141 indexed citations
9.
Íñigo, Pablo, Josep M. Campistol, Ramón Saracho, et al.. (2003). Renoprotective Effects of Losartan in Renal Transplant Recipients. Nephron Clinical Practice. 95(3). c84–c90. 28 indexed citations
10.
Íñigo, Pablo, et al.. (2003). [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].. PubMed. 23(4). 312–20. 13 indexed citations
11.
Pérez‐Calvo, Juan Ignacio, et al.. (2002). Role of Ribavirin in Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection Refractory to Alpha-Interferon. ˜The œNephron journals/Nephron journals. 92(2). 459–462. 6 indexed citations
12.
Esmatjes, Enric, Lílliam Flores, Pablo Íñigo, et al.. (2001). Effect of losartan on TGF‐β1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria. Nephrology Dialysis Transplantation. 16(suppl_1). 90–93. 42 indexed citations
13.
Campistol, Josep M., et al.. (2001). Role of transforming growth factor‐β1 in the progression of chronic allograft nephropathy. Nephrology Dialysis Transplantation. 16(suppl_1). 114–116. 68 indexed citations
14.
Íñigo, Pablo, Josep M. Campistol, Sergio Lario, et al.. (2000). LOSARTAN NORMALIZES THE PLASMA LEVELS OF TGF-β1 IN A RANDOM, CROSSOVER STUDY (LOSARTAN VS. AMLODIPINE) IN RENAL TRANSPLANT PATIENTS TREATED WITH CsA.. Transplantation. 69(Supplement). S402–S402. 2 indexed citations
15.
Íñigo, Pablo, José‐Vicente Torregrosa, Josep M. Campistol, & Federico Oppenheimer. (1999). Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis. Transplantation Proceedings. 31(6). 2321–2321. 10 indexed citations
16.
Torregrosa, José‐Vicente, Pablo Íñigo, Miquel Navasa, et al.. (1999). Combined liver-kidney transplantation: our experience. Transplantation Proceedings. 31(6). 2308–2308. 6 indexed citations
17.
Campistol, Josep M., Pablo Íñigo, Wladimiro Jiménez, et al.. (1999). Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy. Kidney International. 56(2). 714–719. 134 indexed citations
18.
Torregrosa, José‐Vicente, Esteban Poch, Josep Oriola, et al.. (1999). Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene. Transplantation Proceedings. 31(6). 2319–2320. 3 indexed citations
19.
20.
Íñigo, Pablo, Antonio Palacı́n, Josep M. Campistol, et al.. (1999). Differences between acute and chronic renal graft rejection on immunohistochemical staining of transforming growth factor Beta-1. Transplantation Proceedings. 31(6). 2309–2310. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Fellström Breakdown of academic impact, for papers by Margrét B. Andrésdóttir Breakdown of academic impact, for papers by S O Bohman Breakdown of academic impact, for papers by Ivo Lukitsch Breakdown of academic impact, for papers by Maria Van Dyck Breakdown of academic impact, for papers by Blaise Robin Breakdown of academic impact, for papers by G Rifle Breakdown of academic impact, for papers by T Haba Breakdown of academic impact, for papers by Julie Riopel Breakdown of academic impact, for papers by Mazen Arar
Rankless by CCL
2026